ChemicalBook
English   Japanese   Germany   Korea

网站主页 >> CAS数据库列表 >> N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯, 1256388-76-7, 结构式
N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯
CAS号:
1256388-76-7
英文名:
ledipasvir interMediate
英文别名:
N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic;N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester;N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester carbamic acid;Carbamic acid, N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester;N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester (N-2)
中文名:
N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯
中文别名:
雷迪帕韦杂质8;N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯;(S)-1-((S)-6-(5-(7-(2-((1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基)-1H-苯并[D]咪唑-5-基)-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮杂螺[2.4]庚烷-5-基)-3-甲基-2-甲氧碳酰氨基-1-丁酰胺
CBNumber:
CB22710909
分子式:
C42H43F2N7O3
分子量:
731.83
MOL File:
1256388-76-7.mol

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯化学性质

密度:
1.44±0.1 g/cm3(Predicted)
酸度系数(pKa):
10.31±0.10(Predicted)
安全信息

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯性质、用途与生产工艺

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯 上下游产品信息

上游原料

下游产品

N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯 生产厂家

全球有 3家供应商   N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯国内生产厂家
供应商联系电话电子邮件国家产品数优势度
上海德轩医药科技有限公司 1701086315 dexuanpharma@126.com 中国 9478 58
梯希爱（上海）化工贸易有限公司 021-021-61109150 sales@tcisct.com 中国 31133 58
湖南增达生物科技有限公司 18711085600 1652923704@qq.com 中国 4583 58
 

1256388-76-7, N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯 相关搜索:

  • 医药中间体
  • C42H43F2N7O3
  • 雷迪帕韦杂质8
  • (S)-1-((S)-6-(5-(7-(2-((1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基)-1H-苯并[D]咪唑-5-基)-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮杂螺[2.4]庚烷-5-基)-3-甲基-2-甲氧碳酰氨基-1-丁酰胺
  • N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-氮杂双环[2.2.1]庚烷-3-基-1H-苯并咪唑-6-基]-9,9-二氟-9H-芴-2-基]-1H-咪唑-2-基]-5-氮杂螺[2.4]庚烷-5-基]羰基]-2-甲基丙基]氨基甲酸甲酯
  • 1256388-76-7
  • Carbamic acid, N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester
  • N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester carbamic acid
  • N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester (N-2)
  • N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic
  • N-[(1S)-1-[[(6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester
Copyright 2016 © ChemicalBook. All rights reserved